By January 15, 2027, will the study on the PanChol oral cholera vaccine booster trial (NCT05657782), first posted as a preprint on medRxiv, be published in a peer-reviewed journal?

Question 1

A phase 1a booster study for PanChol, a single-dose oral cholera vaccine, suggests a single dose may be sufficient for durable immunity. Publication in a peer-reviewed journal would be a key step towards further clinical development, as existing vaccines require multiple doses and have lower efficacy in children.

Obvious Later · Accepted Answer

Not decided yet. This question is open on Obvious Later until January 15, 2027. The crowd forecast is shown only to people who make their own call first.

Question 2

How does this question resolve?

Obvious Later · Accepted Answer

This question resolves to Yes if the study, registered as NCT05657782, appears in a peer-reviewed journal by the resolution date. The question resolves to No otherwise. Resolution will be determined by searching for the study on PubMed, Google Scholar, and the original medRxiv preprint page, which typically links to the published version.

Question 3

When does this question close?

Obvious Later · Accepted Answer

It closes to new calls on January 15, 2027.

By January 15, 2027, will the study on the PanChol oral cholera vaccine booster trial (NCT05657782), first posted as a preprint on medRxiv, be published in a peer-reviewed journal?

Why it matters

Question provenance

Key evidence

How does this question resolve?

When does this question close?